Assay-kits

SensoLyte® Anti-Mouse/Rat ß-Amyloid (1-40) Quantitative ELISA Kit Colorimetric - 1 kit

$594.00
Check your price
  • Cat.Number : AS-55553
  • Availability :
    In production
  • Shipping conditions : Ice fees will apply

Alternative choices

Quantity

This SensoLyte® high-sensitivity (2pg/ml) beta-Amyloid (1-40) Quantitative ELISA Kit (Mouse/Rat) provides a convenient and quantitative assay for determining mouse/rat beta-Amyloid (1-40) (Aβ40) amount in cell and tissue lysate as well as in body fluids. Compared to other mouse/rat anti-Aβ40 ELISA kits on the market, it takes less time to run this assay. HRP conjugated detection antibody in this kit is added simultaneously with the samples and standards during the assay. This eliminates extra incubation and washing steps and makes this kit a one-step procedure for Aβ40 quantification.

Alzheimer's Disease (AD) is the most common neurodegenerative disorder in elderly people. It has been demonstrated that AD has biological causes and is characterized by the presence of senile plaques and neurofibrillary tangles mainly in cerebral cortex and hippocampus brain regions. Beta-Amyloid (1-40) (Aβ40) and beta-Amyloid (1-42) (Aβ42) are the main components of the above plaques; however, other forms of beta-Amyloid peptides are also present. Both peptides are cleaved from the Amyloid Precursor Protein (APP) by β-secretase and γ-secretase enzymes. Many studies suggest that Aβ42 or/and Aβ43 are required to initiate formation of amyloid plaques and neurofibrills that leads to the neurodegeneration, while Aβ40 is less neurotoxic.

Specifications

Packaging
Kits components
  • Component A: Mouse monoclonal anti-beta-Amyloid (1-40) coated plate: 12 x 8-well strips. Component B: Mouse/rat beta-Amyloid (1-40) Peptide Standard (lyophilized): 1 µg. Component C: 1 X Sample Dilution Buffer: 60 ml. Component D: 10 X Wash Buffer: 30 ml. Component E: TMB Color Substrate Solution: 10 ml. Component F: Stop Solution: 10 ml. Component G: Peptide Standard Reconstitution Buffer: 1 ml. Component H: Detection Antibody (Rabbit anti-Mouse/Rat beta-Amyloid-HRP): 50 µl. Component I: 1 X Detection Antibody Dilution Buffer: 10 ml. Component J: Adhesive Plate Covers: 2 pieces.
Chemistry
UniProt number
  • P12023, P08592
Storage & stability
Storage Conditions
  • Store all components at 4°C for up to 6 months. Component B Reconstituted Peptide Standard must be stored at -80 °C in small aliquots. Protect components E and G from light.
Activity
Application
Biomarker Target
Detection Method
Detection Limit
  • 2 pg/ml
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • Mouse/Rat

You may also be interested in the following product(s)

IMG-EN-AS-72215-01.jpg

AggreSure ß-Amyloid (1-40), human - 0.25 mg

Cat.Number : AS-72215
$330.00 Excl. Tax
IMG-EN-AS-24235-01.jpg

Beta-Amyloid (1-40) Peptide

Cat.Number : AS-24235-
$161.00 Excl. Tax

Citations

ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion

Cell . 2017 Jan 26 ; 168(3) 427 | DOI : https://doi.org/10.1016/j.cell.2016.12.044

  • Y-W A. Huang
  • et al

References

Animal Models of Alzheimer's Disease. Neuronal Models for Studying Tau Pathology

Intl J Alzheimer’s Dis . 2010 Jul 18 ; 2010 528474 | DOI : https://doi.org/10.4061/2010/528474

  • T. Koechling
  • et al

Anti-Aβ42– and anti-Aβ40–specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model

J Clin Invest . 2006 Jan 04 ; 116(1) 193 | DOI : 10.1172/JCI25410

  • Y. Levites
  • et al

APP processing in Alzheimer's disease

Mol Brain . 2011 Jan 07 ; 4 1 | DOI : https://doi.org/10.1186/1756-6606-4-3

  • Y-W. Zhang
  • et al

The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?

Alzheimer’s Res Therapy . 2010 Jul 14 ; 2(12) 1 | DOI : https://doi.org/10.1186/alzrt36

  • K. Broersen
  • et al

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

BMC Neurol . 2010 Nov 03 ; 10(108) | DOI : https://doi.org/10.1186/1471-2377-10-108

  • F. Bermejo-Pareja
  • et al